Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.
As of close of business last night, Immunovant Inc’s stock clocked out at $14.72, down -2.32% from its previous closing price of $15.07. In other words, the price has decreased by -$2.32 from its previous closing price. On the day, 1.15 million shares were traded. IMVT stock price reached its highest trading level at $14.945 during the session, while it also had its lowest trading level at $14.49.
Ratios:
To gain a deeper understanding of IMVT’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 6.04 and its Current Ratio is at 6.04. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Jefferies on March 03, 2025, initiated with a Hold rating and assigned the stock a target price of $20.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Apr 23 ’25 when Stout Jay S sold 1,925 shares for $14.79 per share. The transaction valued at 28,471 led to the insider holds 209,243 shares of the business.
Geffner Michael sold 2,349 shares of IMVT for $34,742 on Apr 23 ’25. The Chief Medical Officer now owns 225,370 shares after completing the transaction at $14.79 per share. On Apr 16 ’25, another insider, Barnett Eva Renee, who serves as the Chief Financial Officer of the company, sold 2,993 shares for $14.89 each. As a result, the insider received 44,566 and left with 396,774 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, IMVT now has a Market Capitalization of 2559793408 and an Enterprise Value of 2125687296.
Stock Price History:
The Beta on a monthly basis for IMVT is 0.77, which has changed by -0.46453255 over the last 52 weeks, in comparison to a change of 0.07995045 over the same period for the S&P500. Over the past 52 weeks, IMVT has reached a high of $34.47, while it has fallen to a 52-week low of $12.72. The 50-Day Moving Average of the stock is -17.54%, while the 200-Day Moving Average is calculated to be -41.84%.
Shares Statistics:
It appears that IMVT traded 1.81M shares on average per day over the past three months and 1492070 shares per day over the past ten days. A total of 147.20M shares are outstanding, with a floating share count of 68.31M. Insiders hold about 59.78% of the company’s shares, while institutions hold 49.43% stake in the company. Shares short for IMVT as of 1744675200 were 20832400 with a Short Ratio of 11.51, compared to 1741910400 on 15799702. Therefore, it implies a Short% of Shares Outstanding of 20832400 and a Short% of Float of 23.809999.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
